Evidence map›Paper›PMID 17186502›Full record

ArticleGlia2007

Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination.

Martha Zeger, Greg Popken, Jihui Zhang, Shouhong Xuan, Q Richard Lu, Markus H Schwab, Klaus-Armin Nave, David Rowitch, A Joseph D'Ercole, Ping Ye

Open access · greenAbstract read
In one paragraph

Article in Glia, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 188 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Regulators of Oligodendrocyte Differentiation.Cold Spring Harbor perspectives in biology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Martha ZegerDepartment of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7039, USA.
Greg Popken
Jihui Zhang
Shouhong Xuan
Q Richard Lu
Markus H Schwab
Klaus-Armin Nave
David Rowitch
A Joseph D'Ercole
Ping Ye
University of North Carolina at Chapel Hill · USMax Planck Society · DEColumbia University · USDana-Farber Cancer Institute · USUniversity of California, San Francisco · US

Funding

INSULIN LIKE GROWTH FACTOR 1 ACTIONS IN OLIGODENDROCYTER01NS038891 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI D'ERCOLE, AUGUSTINE JOSEPH · 1999 to 2007
$2.2M
Mechanism of IGF-I actions on oligodendroglial cellsR01NS048868 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI D'ERCOLE, AUGUSTINE JOSEPH · 2004 to 2008
$1.7M
NINDS NIH HHS R01 NS038891NINDS NIH HHS R01 NS038891-04NINDS NIH HHS R01 NS048868NINDS NIH HHS R01 NS048868-01
6 · The paper itself

Abstract

Insulin-like growth factor-I (IGF-I) has been shown to be a potent agent in promoting the growth and differentiation of oligodendrocyte precursors, and in stimulating myelination during development and following injury. To definitively determine whether IGF-I acts directly on the cells of oligodendrocyte lineage, we generated lines of mice in which the type 1 IGF receptor gene (igf1r) was conditionally ablated either in Olig1 or proteolipid protein expressing cells (termed IGF1R(pre-oligo-ko) and IGF1R(oligo-ko) mice, respectively). Compared with wild type mice, IGF1R(pre-oligo-ko) mice had a decreased volume (by 35-55%) and cell number (by 54-70%) in the corpus callosum (CC) and anterior commissure at 2 and 6 weeks of age, respectively. IGF1R(oligo-ko) mice by 25 weeks of age also showed reductions, albeit less marked, in CC volume and cell number. Unlike astrocytes, the percentage of NG2(+) oligodendrocyte precursors was decreased by approximately 13% in 2-week-old IGF1R(pre-oligo-ko) mice, while the percentage of CC1(+) mature oligodendrocytes was decreased by approximately 24% in 6-week-old IGF1R(pre-oligo-ko) mice and approximately 25% in 25-week-old IGF1R(oligo-ko) mice. The reduction in these cells is apparently a result of decreased proliferation and increased apoptosis. These results indicate that IGF-I directly affects oligodendrocytes and myelination in vivo via IGF1R, and that IGF1R signaling in the cells of oligodendrocyte lineage is required for normal oligodendrocyte development and myelination. These data also provide a fundamental basis for developing strategies with the potential to target IGF-IGF1R signaling pathways in oligodendrocyte lineage cells for the treatment of demyelinating disorders.

Indexed as

AnimalsBlotting, SouthernBlotting, WesternCell LineageCorpus CallosumDentate GyrusExonsImmunohistochemistryIn Situ Nick-End LabelingLac OperonMiceMice, KnockoutMyelin SheathOligodendrogliaReceptor, IGF Type 1Signal TransductionReceptor, IGF Type 1

Identifiers

PMID17186502
PMCPMC1774584
OpenAlexW2042528531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.